Vilin Bio Med Limited (NSE:VILINBIO)
India · Delayed Price · Currency is INR 34.25
-0.20 (-0.58%)
Mar 6, 2026, 3:24 PM IST
Vilin Bio Med Revenue
Vilin Bio Med had revenue of 96.64M INR in the half year ending September 30, 2025, with 24.64% growth. This brings the company's revenue in the last twelve months to 199.81M, up 52.70% year-over-year. In the fiscal year ending March 31, 2025, Vilin Bio Med had annual revenue of 148.10M, down -6.30%.
Revenue (ttm)
199.81M
Revenue Growth
+52.70%
P/S Ratio
2.39
Revenue / Employee
n/a
Employees
n/a
Market Cap
477.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 148.10M | -9.95M | -6.30% |
| Mar 31, 2024 | 158.05M | 34.68M | 28.11% |
| Mar 31, 2023 | 123.37M | 11.18M | 9.97% |
| Mar 31, 2022 | 112.19M | -5.00M | -4.26% |
| Mar 31, 2021 | 117.19M | -51.05M | -30.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 7.48B |
| Accent Microcell | 2.78B |
| Infinium Pharmachem | 1.57B |
| Zenith Drugs | 1.44B |
| Quest Laboratories | 1.26B |
| Sotac Pharmaceuticals | 846.72M |
| Sunrest Lifescience | 520.34M |
| Medicamen Organics | 394.30M |